May 1, 2019
Toronto, Canada. (May 1, 2019) Benetech Inc. is a software development company that creates and markets tools for use in prenatal screening. Its flagship product, Benetech PRA™ is used by hundreds of leading hospitals and labs around the world to screen millions of pregnancies each year for congenital anomalies.
Benetech announced today the release of Benetech PRA version 126.96.36.199. as well as simultaneous release of Benetech HL7 Interface version 188.8.131.52. Benetech PRA and HL7 3.4 release contains several significant product enhancements, including; the introduction of Enhanced First Trimester Screening – supporting the use of AFP as a first trimester marker and the ability to adjust NTD prevalence factors for Valproic Acid (VPA), Selective Serotonin Reuptake Inhibitors (SSRI), and Carbamazepine (CBZ) as well as many more features.
Benetech PRA version 3.4 also includes a number of other new features, such as – setting GA upper limit for Second Trimester Screening up to 24 weeks 6 days, added option for ONTD history, extended upper CRL measurement to 85 mm, and enhanced reporting capability – save Twin MoM report using custom key, AChE result printed as “Not Screened” when testing done but beyond GA range, introduced coordinates for disclaimer on report format 3, and the ability to run Weight Correction reports with and without factors.
“PRA version 3.4 proves Benetech’s commitment to maintain and develop quality clinical software solutions for our clients” said Les Hansen, President of Benetech Inc.“This new version of PRA provides several new features necessary for labs to perform screening with up-to-date parameters while continuing to be customizable and compatible with any workflow.”
Benetech PRA and HL7 3.4 is now available as a free download to all Benetech customers with a current Annual User Service Contract in place. Customers interested in upgrading to PRA 3.4 can contact the company at firstname.lastname@example.org for assistance.
1 800 253 8611
About Benetech Inc.
Located in Toronto Canada, Benetech was founded in 1987 and has been privately owned and operated ever since. Benetech PRA is used by many of the leading hospitals and labs in the world and is considered a gold standard for prenatal screening. The quality systems of Benetech Inc. have been registered by UL LLC. to ISO 13485:2016. More information on Benetech Inc. and its products can be found at www.benetech.com or by contacting email@example.com.